• Translational Development Acquisition Corp. held a shareholder meeting on June 17, 2026, to vote on extending the SPAC’s life.
• Shareholders adopted the extension proposal.
• Redemptions were elected for 2,598,697 Class A shares; 14,651,303 Class A shares remained outstanding.
• Trust balance stood at about USD 156.8 million following the redemptions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Translational Development Acquisition Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606220705PR_NEWS_USPR_____NY88401) on June 22, 2026, and is solely responsible for the information contained therein.